CXCL8 and hepatocellular carcinoma: As for HCC staging, the level of serum IL-8 was found to be around two-times higher in BCLC B (25.4 [10.3 – 53.9]) compared to BCLC A group (11.9 [2.3 – 23.9]) (p<0.05)].